Integral Investment Advisors’s Gilead Sciences GILD Stock Holding History

Integral Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$578K	Hold	4,577	–	–	0.13%	100
2026 Q1	$638K	Hold	4,577	–	–	0.16%	93
2025 Q4	$562K	Buy	4,577 +470	+11%	+$57.1K	0.14%	99
2025 Q3	$456K	Hold	4,107	–	–	0.12%	103
2025 Q2	$455K	Buy	4,107 +18	+0.4%	+$1.92K	0.13%	103
2025 Q1	$458K	Hold	4,089	–	–	0.15%	101
2024 Q4	$378K	Hold	4,089	–	–	0.12%	112
2024 Q3	$343K	Buy	4,089 +21	+0.5%	+$1.6K	0.11%	120
2024 Q2	$280K	Sell	4,068 -4	-0.1%	-$267	0.1%	123
2024 Q1	$297K	Buy	+4,072	New	+$313K	0.12%	115

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integral Investment Advisors's GILD Position: Q2 2026 in Review

Integral Investment Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,577 shares worth $578K. The position accounts for 0.13% of the portfolio, ranked #100.

Integral Investment Advisors first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $638K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Integral Investment Advisors held 4,577 shares of Gilead Sciences worth $578K as of Q2 2026.
Integral Investment Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.13% of Integral Investment Advisors's portfolio in Q2 2026, its #100 holding.
Integral Investment Advisors first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
Integral Investment Advisors's Gilead Sciences position peaked at $638K in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.